Agena Bioscience - rapid & accurate genetic testing solutions.

Advancing Clinical Science

UltraSEEK^™ Lung and Colon Cancer Research Panels Now Available

Identify variants of known significance
Assess plasma and tissue samples in parallel
Monitor disease progression from ctDNA and CTCs

Learn More

Areas of Interest

Meeting Your Lab's Needs with the MassARRAY^® System

The MassARRAY System enables one-day turnaround times on genetic tests. Best of all, it’s easily integrated into your everyday workflow and scalable to your assay and sample needs.

Sensitive

Accurate

Cost Effective

Efficient Workflow

Flexible

See How it Works

Featured Publications View All

Characterization of Three CYP2C19 Gene Variants by MassARRAY and Point of Care Techniques: Experience from a Czech Centre

by M Petrek | Arch Immunol Ther Exp

Abstract: Distribution of cytochrome P450 2C19 enzyme gene (CYP2C19) variants affecting metabolism of clopidogrel was determined in 526 Czech patients after percutaneous coronary intervention... Read More

KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior

by S Jang | Human Pathol

Abstract: A high-grade tumor budding in colorectal adenocarcinomas was correlated with KRAS mutations. Especially, KRAS G12D mutations were associated with a high-grade tumor... Read More

Interactions among polymorphisms of NER genes prompt the risk of transplantation rejection

by W Bengang | Yi Chuan

Abstract: Better efficacy for predicting the risk of transplantation rejection could be achieved by intergenic interactions among single nucleotide polymorphisms (SNPs) compared with one... Read More

Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer

by T-M Rogers | Sci Rep.

Abstract: ALK, ROS1 and RET gene fusions are important predictive biomarkers for tyrosine kinase inhibitors in lung cancer. Currently, the gold standard method for... Read More

Who We Are

Our mission is to empower the translation of genomic discoveries into mainstream clinical practice. With the MassARRAY System, we have helped hundreds of labs transition genetic assays into routine practice for:

Genotyping (SNPs, indels, and CNVs)
Tumor Profiling
Liquid Biopsy
Methylation Analysis

Learn More About Us

102. Jahrestagung der Deutschen Gesellschaft für Pathologie

Booth #30

When: 24 May 2018 - 26 May 2018
Where: Berlin, Germany

Visit Event Website

View All Events

Learn more about how the MassARRAY System will keep your lab at the forefront of technology.

Request Pricing & Info

Advancing Clinical Science

Areas of Interest

Oncology and Liquid Biopsy

Pharmacogenetics

Sample Identification

Meeting Your Lab's Needs with the MassARRAY^® System

Sensitive

Accurate

Cost Effective

Efficient Workflow

Flexible

Featured Publications View All

Characterization of Three CYP2C19 Gene Variants by MassARRAY and Point of Care Techniques: Experience from a Czech Centre

KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior

Interactions among polymorphisms of NER genes prompt the risk of transplantation rejection

Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer

Who We Are

Latest Press View All

Agena and Simceredx Announce Strategic Partnership to Develop and Commercialize Companion Diagnostics in China

Agena Bioscience’s Liquid Biopsy Technology Awarded Horizon 2020 Grant by European Union

Agena Bioscience Bolsters MassARRAY Insights™ Reporting Network by Adding N-of-One

102. Jahrestagung der Deutschen Gesellschaft für Pathologie

Learn more about how the MassARRAY System will keep your lab at the forefront of technology.

Advancing Clinical Science

Areas of Interest

Oncology and Liquid Biopsy

Pharmacogenetics

Sample Identification

Meeting Your Lab's Needs with the MassARRAY® System

Sensitive

Accurate

Cost Effective

Efficient Workflow

Flexible

Featured Publications View All

Characterization of Three CYP2C19 Gene Variants by MassARRAY and Point of Care Techniques: Experience from a Czech Centre

KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior

Interactions among polymorphisms of NER genes prompt the risk of transplantation rejection

Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer

Who We Are

Latest Press View All

Agena and Simceredx Announce Strategic Partnership to Develop and Commercialize Companion Diagnostics in China

Agena Bioscience’s Liquid Biopsy Technology Awarded Horizon 2020 Grant by European Union

Agena Bioscience Bolsters MassARRAY Insights™ Reporting Network by Adding N-of-One

102. Jahrestagung der Deutschen Gesellschaft für Pathologie

Learn more about how the MassARRAY System will keep your lab at the forefront of technology.

Meeting Your Lab's Needs with the MassARRAY^® System